ArticleJournal of bone oncology2024

Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal.

Gennady N Machak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.